跳至主要内容
临床试验/JPRN-UMIN000002240
JPRN-UMIN000002240招募中未知

Therapeutic effect of mosapride and lansoprazole for the prevention of aspiration pnumonia in patiets treated by gastrostomy feeding - Prevention of aspiration pnumonia

Shimane University0 个研究点目标入组 150 人开始时间: 2009年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

已完成
4 期
Comparative Efficacy of Omeprazole plus Mosapride Combination Therapy versus Omeprazole Monotherapy in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease: a randomized controlled trialproton pump inhibitor refractory gastroesophageal reflux diseasemosaprideproton pump inhibitorgastroesophageal reflux diseasecombined therapy
TCTR20190418003Rajavithi Hospital44
Unknown
3 期
The efficacy and safety of mosapride compared with domperidone in Parkinson's disease with gastroparesis; A randomized, double blind, double dummy studyGastroparesis in Parkinsons diseaseParkinsons diseaseGastric emptying timeMosaprideDomperidoneProkineticGastroparesis
TCTR20220821001Faculty of Medicine, Prince of Songkla University60
招募中
不适用
Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs(1)continuous in use about NSAIDs aged 20 and over. (2) The patient who has an anamnesis of digestive ulcer. (3) The patient at least whose one item it is at the research registration time and is three or more points in the question item of a GOS interview sheet. (4) Those by whom the consent of research participation was got with the document.
JPRN-UMIN000008736Department of Orthopaedic Surgery Shimane University School of Medicine400
招募中
不适用
A randomized, prospective, double-blind clinical trial of the effect of mosapride in patients with small intestinal bacterial overgrowthDiseases of the digestive system
KCT0004994The Catholic University of Korea, St. Vincent's Hospital87
已完成
4 期
The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin HormonesDiabetes Mellitus, Type 2
NCT02180334Seoul National University Hospital12